0000899243-23-003743.txt : 20230202 0000899243-23-003743.hdr.sgml : 20230202 20230202203038 ACCESSION NUMBER: 0000899243-23-003743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Larue Catherine CENTRAL INDEX KEY: 0001823057 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 23583381 MAIL ADDRESS: STREET 1: C/O QUOTIENT LIMITED, B1, BUSINESS PARK STREET 2: TERRE BONNE, ROUTE DE CRASSIER 13 CITY: EYSINS STATE: V8 ZIP: 1262 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-31 0 0001596946 Quotient Ltd QTNT 0001823057 Larue Catherine C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, ROUTE DE CRASSIER 13 EYSINS V8 1262 SWITZERLAND 1 0 0 0 Ordinary Shares 2023-01-31 4 M 0 438 A 1618 D Ordinary Shares Option (Right to buy) 192.40 2030-09-01 Ordinary Shares 519 519 D Ordinary Share Option (Right to Buy) 192.40 2030-09-01 Ordinary Shares 54 54 D Ordinary Share Option (Right to Buy) 182.00 2030-10-31 Ordinary Shares 340 340 D Ordinary Share Option (Right to Buy) 101.20 2031-10-31 Ordinary Shares 601 601 D Restricted Stock Units 2023-01-31 4 M 0 438 0.00 D Ordinary Shares 438 1312 D Ordinary Share Option (Right to Buy) 5.20 2032-10-31 Ordinary Shares 1000 1000 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. All 519 options have vested and remain exercisable. All 54 options have vested and remain exercisable. All 340 options have vested and remain exercisable. All 601 options have vested and remain exercisable. On October 31, 2022, the Reporting Person was granted 1,750 restricted stock units, of which 438 have vested and have converted into ordinary shares. The remaining 1,312 restricted stock units will vest in three equal installments on April 30, 2023, July 31, 2023 and October 31, 2023. The options vest and become exercisable on October 31, 2023. /s/ Catherine Larue 2023-02-02